These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 4592525)

  • 1. [Clinical considerations on the use of an antispastic-antivagal drug association in the cholecysto-coronary syndrome].
    Cristiano P; Panzitta S; Cuiuli V; Petronio A; Giraldi A
    Minerva Gastroenterol; 1973; 19(4):259-69. PubMed ID: 4592525
    [No Abstract]   [Full Text] [Related]  

  • 2. [A new 2-phase coronary agent for the treatment of angina pectoris due to coronary disease].
    Gill E
    Med Welt; 1978 Mar; 29(10):408-11. PubMed ID: 416316
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment of coronary insufficiency with a combination of 2 nitro-derivatives. Controlled pluricentric clinical trial].
    Di Prisco AU; Vaccari GL; Soro A; Mora A
    Minerva Med; 1975 Feb; 66(12):551-61. PubMed ID: 1113905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Timed-release pentaerythritol tetranitrate and placebo in the management of angina pectoris.
    Cole RE; Goldberg RI
    Curr Ther Res Clin Exp; 1967 Nov; 9(11):551-7. PubMed ID: 4965503
    [No Abstract]   [Full Text] [Related]  

  • 5. [The drug therapy effect on functional and organic stenocardias].
    Gill E
    Med Klin; 1966 Aug; 61(32):1258-60. PubMed ID: 4870033
    [No Abstract]   [Full Text] [Related]  

  • 6. [Combination therapy of angina pectoris vera with coronary active substances and Faustan].
    Nossing R; Gruber G; Schmidt P
    Z Arztl Fortbild (Jena); 1971 Jun; 65(12):589-91. PubMed ID: 5000186
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical data on 20 patients treated with the association of butydrine and pentaerythritol tetranitrate].
    Rossi PL; Guarraggi A; Anfossi F
    Clin Ter; 1971 May; 57(4):345-50. PubMed ID: 5110948
    [No Abstract]   [Full Text] [Related]  

  • 8. A clinical study comparing the effect of small doses of heparin with the effects of carbocromen and pentaerythrityl tetranitrate in angina pectoris. Some questions of the therapeutical mechanism of heparin.
    Goldberg GA; Suriadnova BA; Stepanov MA; Kochanko EP
    Cor Vasa; 1972; 14(2):81-95. PubMed ID: 5050956
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of coronary angina. Use of a delayed-action nitrate derivative].
    Giard
    J Sci Med Lille; 1972 Nov; 90(11):407-10. PubMed ID: 4650213
    [No Abstract]   [Full Text] [Related]  

  • 10. Exercise tolerance in patients with angina pectoris: daily variation and effect of pentaerythritol tetranitrate.
    Dagenais GR; Mason RE; Friesinger GC; Wender C; Ross RS
    Johns Hopkins Med J; 1969 Dec; 125(6):301-11. PubMed ID: 4905736
    [No Abstract]   [Full Text] [Related]  

  • 11. [Therapeutic possibilities in coronary disease].
    Zoli I; Baroncini S; Cornia GL; Donato S; Minore G; Pigini G; Pretolani E
    Minerva Med; 1973 Nov; 64(84):4445-57. PubMed ID: 4272415
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical results of the use of a new drug association in heart diseases].
    Chierici F; Artuso P; Suriani L
    Clin Ter; 1970 Feb; 52(3):219-57. PubMed ID: 5419244
    [No Abstract]   [Full Text] [Related]  

  • 13. [Anti-anginal activity of a beta-adrenergic blocking agent, butydrine, alone and in association with pentaerythritol tetranitrate, in the aged].
    Gatti A; Scotti G
    Clin Ter; 1967 May; 41(4):363-74. PubMed ID: 5614306
    [No Abstract]   [Full Text] [Related]  

  • 14. [Therapy and prevention of ischemic heart diseases].
    Gill E
    Z Allgemeinmed; 1973 Oct; 49(28):1354-6. PubMed ID: 4756675
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical use of a combination of butydrine and pentaerythrol in coronary insufficiency].
    Ballerini A
    Minerva Cardioangiol; 1971 May; 19(5):272-6. PubMed ID: 4397515
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical experience with the association of a beta-blocking agent and pentaerythrite].
    Barbi G; Tallone G
    Minerva Cardioangiol; 1969 Feb; 17(2):139-41. PubMed ID: 5777637
    [No Abstract]   [Full Text] [Related]  

  • 17. New dimension in angina pectoris therapy.
    Russek HI
    Geriatrics; 1969 Mar; 24(3):81-95. PubMed ID: 4885554
    [No Abstract]   [Full Text] [Related]  

  • 18. [Comparative study of the treatment of angina pectoris with nitrong, papaverine, erinit and euphylline].
    Volkov VS; Bratoliubov VP
    Sov Med; 1985; (7):77-80. PubMed ID: 3934766
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical evaluation of the therapeutic action of a beta-blocking agent associated with a nitroderivative].
    Salmini G; Cione R; Oldrini R
    Minerva Cardioangiol; 1970 May; 18(5):311-5. PubMed ID: 5515015
    [No Abstract]   [Full Text] [Related]  

  • 20. [Angina pectoris: clinical estimation of prophylaxis in open units].
    Finnson M; Nyberg G
    Lakartidningen; 1969 Dec; 66(49):5137-45. PubMed ID: 4908066
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.